InsidersTradesSigma
Total declarations
Companies
▲ Purchases (18 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Sirgo Mark A, Director. Director active across 2 companies, notably Biodelivery Sciences International INC. In total, 27 filings have been logged. Total volume traded: €749k. The latest transaction was disclosed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations27 total
€47,743106,383 shares@ €0.448811.2% of flow
Common Stock
SEC:0001578563-22-000016:0·
Ideal exit: 12 Feb 2023 (T+270)
01,166,866 shares0
Common Stock
SEC:0001103021-22-000071:0·
€44,99786,449.55 shares@ €0.520510.6% of flow
Common stock
SEC:0001551986-22-000023:0·
Ideal exit: 28 Nov 2022 (T+270)
07,684 shares0
Common Stock
SEC:0001103021-22-000023·
07,684 shares0
Common Stock
SEC:0001103021-22-000023:0·
€44,17118,587 shares@ €2.376427.3% of flow
Common Stock
SEC:0001103021-21-000124·
Ideal exit: 29 Aug 2022 (T+270)
€44,17118,587 shares@ €2.376413.6% of flow
Common Stock
SEC:0001103021-21-000124:0·
Ideal exit: 29 Aug 2022 (T+270)
€39,31350,000 shares@ €0.786323.7% of flow
Common Stock
SEC:0001578563-21-000044·
Ideal exit: 29 Aug 2022 (T+270)
€39,31350,000 shares@ €0.78639.3% of flow
Common Stock
SEC:0001578563-21-000044:0·
Ideal exit: 29 Aug 2022 (T+270)
€18,72620,000 shares@ €0.936311.3% of flow
Common stock
SEC:0001551986-21-000122·
Ideal exit: 15 Aug 2022 (T+270)
€18,72620,000 shares@ €0.93634.4% of flow
Common stock
SEC:0001551986-21-000122:0·
Ideal exit: 15 Aug 2022 (T+270)
€26,85210,000 shares@ €2.685216.6% of flow
Common Stock
SEC:0001103021-21-000116·
€26,85210,000 shares@ €2.685216.6% of flow
Common Stock
SEC:0001103021-21-000118·
Ideal exit: 15 Aug 2022 (T+270)
€26,85210,000 shares@ €2.68528.3% of flow
Common Stock
SEC:0001103021-21-000116:0·
€26,85210,000 shares@ €2.68528.3% of flow
Common Stock
SEC:0001103021-21-000118:0·
Ideal exit: 15 Aug 2022 (T+270)
€44,57616,000 shares@ €2.78627.5% of flow
Common Stock
SEC:0001103021-21-000112·
Ideal exit: 8 Aug 2022 (T+270)
€44,57616,000 shares@ €2.78613.8% of flow
Common Stock
SEC:0001103021-21-000112:0·
Ideal exit: 8 Aug 2022 (T+270)
€84,43473,529 shares@ €1.148350.9% of flow
Common stock
SEC:0001551986-21-000101·
Ideal exit: 4 Jun 2022 (T+270)
€84,43473,529 shares@ €1.148319.9% of flow
Common stock
SEC:0001551986-21-000101:0·
Ideal exit: 4 Jun 2022 (T+270)
04,000 shares0
Common Stock
SEC:0001103021-21-000082·
04,000 shares0
Common Stock
SEC:0001103021-21-000082:0·
€23,55125,000 shares@ €0.942114.2% of flow
Common stock
SEC:0001551986-21-000097·
Ideal exit: 17 May 2022 (T+270)
€23,55125,000 shares@ €0.94215.5% of flow
Common stock
SEC:0001551986-21-000097:0·
Ideal exit: 17 May 2022 (T+270)
04,000 shares0
Common Stock
SEC:0001103021-21-000078·
04,000 shares0
Common Stock
SEC:0001103021-21-000078:0·
25 of 27 declarations
About Sirgo Mark A
Mark A Sirgo is an executive at BIODELIVERY SCIENCES INTERNATIONAL INC.
